Cargando…
Assessing parasite clearance during uncomplicated Plasmodium falciparum infection treated with artesunate monotherapy in Suriname
BACKGROUND: Artemisinin resistance in Plasmodium falciparum is suspected when the day 3 parasitemia is >10% when treated with artemisinin-based combination therapy or if >10% of patients treated with artemisinin-based combination therapy or artesunate monotherapy harbored parasites with half-l...
Autores principales: | Vreden, Stephen GS, Bansie, Rakesh D, Jitan, Jeetendra K, Adhin, Malti R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126040/ https://www.ncbi.nlm.nih.gov/pubmed/27920563 http://dx.doi.org/10.2147/IDR.S113861 |
Ejemplares similares
-
Evidence of an increased incidence of day 3 parasitaemia in
Suriname: an indicator of the emerging resistance of Plasmodium
falciparum to artemether
por: Vreden, Stephen GS, et al.
Publicado: (2013) -
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
por: Mac Donald-Ottevanger, M Sigrid, et al.
Publicado: (2017) -
Gold mining areas in Suriname: reservoirs of malaria resistance?
por: Adhin, Malti R, et al.
Publicado: (2014) -
Status of potential PfATP6 molecular markers for artemisinin resistance in Suriname
por: Adhin, Malti R, et al.
Publicado: (2012) -
Malaria serology data from the Guiana shield: first insight in IgG antibody responses to Plasmodium falciparum, Plasmodium vivax and Plasmodium malariae antigens in Suriname
por: Labadie-Bracho, Mergiory Y., et al.
Publicado: (2020)